TKO Group (NYSE:TKO) Price Target Raised to $250.00
TKO Group (NYSE:TKO – Free Report) had its target price lifted by Pivotal Research from $235.00 to $250.00 in a research report released on Thursday morning, Marketbeat.com reports. They currently have a buy rating on the stock. TKO has been the topic of a number of other research reports. Weiss Ratings restated a “hold (c)” […]
Lantheus (NASDAQ:LNTH) Price Target Raised to $85.00 at Mizuho
Lantheus (NASDAQ:LNTH – Free Report) had its price objective increased by Mizuho from $72.00 to $85.00 in a research note published on Friday morning,Benzinga reports. Mizuho currently has an outperform rating on the medical equipment provider’s stock. Several other research analysts also recently weighed in on the stock. Citigroup restated an “outperform” rating on shares […]
Zscaler (NASDAQ:ZS) Given New $290.00 Price Target at Citizens Jmp
Zscaler (NASDAQ:ZS – Free Report) had its price objective reduced by Citizens Jmp from $355.00 to $290.00 in a research note published on Friday morning,Benzinga reports. They currently have a market outperform rating on the stock. ZS has been the subject of a number of other research reports. Rosenblatt Securities reiterated a “buy” rating and […]
Zscaler (NASDAQ:ZS) Given New $320.00 Price Target at Berenberg Bank
Zscaler (NASDAQ:ZS – Free Report) had its price target cut by Berenberg Bank from $390.00 to $320.00 in a research note issued to investors on Friday,MarketScreener reports. They currently have a buy rating on the stock. A number of other brokerages have also weighed in on ZS. KeyCorp decreased their target price on Zscaler from […]
FIGS (NYSE:FIGS) Given New $15.00 Price Target at Telsey Advisory Group
FIGS (NYSE:FIGS – Free Report) had its price objective hoisted by Telsey Advisory Group from $9.00 to $15.00 in a research note released on Friday morning, MarketBeat Ratings reports. Telsey Advisory Group currently has a market perform rating on the stock. Several other equities analysts also recently weighed in on FIGS. The Goldman Sachs Group […]
BMO Capital Markets Cuts Okta (NASDAQ:OKTA) Price Target to $83.00
Okta (NASDAQ:OKTA – Free Report) had its price objective reduced by BMO Capital Markets from $90.00 to $83.00 in a research note published on Thursday, MarketBeat reports. BMO Capital Markets currently has a market perform rating on the stock. A number of other research firms also recently weighed in on OKTA. Morgan Stanley reduced their […]
Par Pacific (NYSE:PARR) Price Target Raised to $48.00 at TD Cowen
Par Pacific (NYSE:PARR – Free Report) had its price objective upped by TD Cowen from $39.00 to $48.00 in a research note issued to investors on Friday, Marketbeat Ratings reports. TD Cowen currently has a buy rating on the stock. Several other equities analysts have also weighed in on PARR. Tudor Pickering upgraded shares of […]
Elastic (NYSE:ESTC) Given New $90.00 Price Target at Canaccord Genuity Group
Elastic (NYSE:ESTC – Free Report) had its price target reduced by Canaccord Genuity Group from $115.00 to $90.00 in a research note released on Friday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. ESTC has been the subject of several other reports. JPMorgan Chase & Co. dropped their price objective […]
Janux Therapeutics (NASDAQ:JANX) Given New $100.00 Price Target at Cantor Fitzgerald
Janux Therapeutics (NASDAQ:JANX – Free Report) had its price objective cut by Cantor Fitzgerald from $150.00 to $100.00 in a report published on Friday,Benzinga reports. They currently have an overweight rating on the stock. Other research analysts also recently issued research reports about the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of […]
CoreWeave (NASDAQ:CRWV) Given Overweight Rating at Cantor Fitzgerald
Cantor Fitzgerald reissued their overweight rating on shares of CoreWeave (NASDAQ:CRWV – Free Report) in a research report released on Friday morning,Benzinga reports. Cantor Fitzgerald currently has a $131.00 price target on the stock. A number of other research firms also recently weighed in on CRWV. Mizuho raised their price target on shares of CoreWeave […]
Chemed (NYSE:CHE) Given Sector Perform Rating at Royal Bank Of Canada
Royal Bank Of Canada reaffirmed their sector perform rating on shares of Chemed (NYSE:CHE – Free Report) in a report released on Friday morning, MarketBeat reports. They currently have a $422.00 price objective on the stock, down from their previous price objective of $572.00. Several other brokerages also recently commented on CHE. Jefferies Financial Group […]
Cars.com’s (CARS) “Neutral” Rating Reaffirmed at JPMorgan Chase & Co.
JPMorgan Chase & Co. reissued their neutral rating on shares of Cars.com (NYSE:CARS – Free Report) in a research note released on Friday, MarketBeat Ratings reports. JPMorgan Chase & Co. currently has a $10.00 price target on the stock, down from their previous price target of $16.00. Other analysts have also recently issued reports about […]
Viridian Therapeutics (NASDAQ:VRDN) Price Target Lowered to $42.00 at Royal Bank Of Canada
Viridian Therapeutics (NASDAQ:VRDN – Free Report) had its price objective trimmed by Royal Bank Of Canada from $45.00 to $42.00 in a report issued on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock. A number of other brokerages also recently issued reports on VRDN. Wedbush upped their price target on […]
ODDITY Tech’s (ODD) “Neutral” Rating Reiterated at JPMorgan Chase & Co.
JPMorgan Chase & Co. reiterated their neutral rating on shares of ODDITY Tech (NASDAQ:ODD – Free Report) in a research report sent to investors on Thursday morning, Marketbeat Ratings reports. JPMorgan Chase & Co. currently has a $16.00 target price on the stock, down from their prior target price of $59.00. A number of other […]
GoodRx (NASDAQ:GDRX) Given “Neutral” Rating at JPMorgan Chase & Co.
JPMorgan Chase & Co. restated their neutral rating on shares of GoodRx (NASDAQ:GDRX – Free Report) in a research report released on Friday, Marketbeat Ratings reports. Several other research firms have also commented on GDRX. Mizuho reduced their price target on GoodRx from $5.00 to $4.00 and set a “neutral” rating on the stock in […]
BlackSky Technology (NYSE:BKSY) Price Target Cut to $26.00 by Analysts at Canaccord Genuity Group
BlackSky Technology (NYSE:BKSY – Free Report) had its target price reduced by Canaccord Genuity Group from $27.00 to $26.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have a buy rating on the stock. A number of other analysts also recently weighed in on the company. HC Wainwright reiterated a […]
last updated on 1 Mar 07:39